The Bidirectional Association of Chronic Kidney Disease, Type 2 Diabetes, Atherosclerotic Cardiovascular Disease, and Heart Failure: The Cardio–Renal–Metabolic Syndrome
- 16 June 2023
- journal article
- research article
- Published by SAGE Publications in Metabolic Syndrome and Related Disorders
- Vol. 21 (5) , 261-266
Abstract
Background: The cardiometabolic syndrome focuses on the association between type 2 diabetes mellitus (T2DM) and atherosclerotic cardiovascular disease (ASCVD), whereas the cardiorenal syndrome focuses on the association between chronic kidney disease (CKD) and heart failure (HF). Consideration of these two syndromes as a single entity has not been well described. Methods: We used the electronic medical records of Kaiser Permanente Northwest to identify 387,985 members aged 18+ years with a serum creatinine measured from 2005 to 2017. If the estimated glomerular filtration rate was 2 , we required a second confirmatory measurement 3–12 months later. Patients were followed through 2019. We calculated the age- and gender-adjusted incidence and progression of CKD per 1000 person-years using generalized estimating equations. We used Cox proportional hazard models to assess the time-dependent effect of each condition on incidence of the other conditions. Results: CKD incidence rates were highest in patients with T2DM, ASCVD, and HF (27.0 per 1000 person-years [95% confidence interval (CI) 24.8–29.4] vs. 5.9 [5.8–6.0] in patients with none of these conditions). Similar results were obtained for CKD progression (309.0, 283.9–336.4 for all three conditions vs. 147.9, 143.3–152.4 for no condition). In time-dependent models, all three conditions were independently associated with CKD incidence, being highest for HF (hazard ratio 2.14, 95% CI 2.07–2.21). All relationships between CKD, T2DM, ASCVD, and HF were significant and bidirectional. Conclusions: The presence of CKD, T2DM, HF, and ASCVD each conveys risk on the others. A cardiometabolic renal syndrome comprising these conditions may be an important disease entity that requires a comprehensive treatment approach.Keywords
This publication has 17 references indexed in Scilit:
- ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKDAmerican Journal of Kidney Diseases, 2017
- Heart failure in patients with kidney diseaseHeart, 2017
- Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort studyThe Lancet Diabetes & Endocrinology, 2016
- Demographic characteristics of members of the Vaccine Safety Datalink (VSD): A comparison with the United States populationVaccine, 2015
- Risk factors for chronic kidney disease: an updateKidney International Supplements, 2013
- Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and preventionThe Lancet, 2013
- Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort studyThe Lancet, 2012
- A New Equation to Estimate Glomerular Filtration RateAnnals of Internal Medicine, 2009
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationNew England Journal of Medicine, 2004
- Cardiometabolic syndrome: Pathophysiology and treatmentCurrent Hypertension Reports, 2003